ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Investment

Boehringer Ingelheim to build a biologics research center

by Rick Mullin
June 30, 2018 | APPEARED IN VOLUME 96, ISSUE 27

 

Boehringer Ingelheim will build a $270 million biologics development center at its site in Biberach, Germany. The facility will combine analytical and process development with clinical-scale manufacturing, according to Fridtjof Traulsen, Boehringer’s vice president of development. It will also free up capacity for contract manufacturing. The company expects that the center, to open in 2020, will house a workforce of 500.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment